All sponsors

Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS6
PHASE 3 / 2-36
RECRUITING6
READOUTS ≤12 MONTHS3
Open Karuna Therapeutics, Inc., a Bristol Myers Squibb company on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
KarXT
NCT05511363
P3RecruitingPsychosis Associated With Alzheimer's Disease4102026-10-05 (+19 mo)
KarXT
NCT06585787
P3RecruitingAlzheimer Disease4062026-11-24
KarXT
NCT06126224
P3RecruitingPsychosis Associated With Alzheimer's Disease5002026-12-09 (+17 mo)
KarXT
NCT05980949
P3RecruitingPsychosis Associated With Alzheimer's Disease10002027-09-07 (+17 mo)
Xanomeline/Trospium Chloride
NCT07686263
P3RecruitingSchizophrenia4722029-03-03
KarXT
NCT07424404
P3RecruitingSchizophrenia; Autism-Related Irritability4002030-03-08